Goldman Sachs Group Inc Evolent Health, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Evolent Health, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,081,882 shares of EVH stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,081,882
Previous 610,746 77.14%
Holding current value
$10.8 Million
Previous $17.3 Million 29.53%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$10.71 - $27.14 $5.05 Million - $12.8 Million
471,136 Added 77.14%
1,081,882 $12.2 Million
Q3 2024

Nov 14, 2024
BUY
$18.41 - $32.97 $5,964 - $10,682
324 Added 0.05%
610,746 $17.3 Million
Q2 2024

Aug 13, 2024
SELL
$19.12 - $31.93 $1.2 Million - $2.01 Million
-62,964 Reduced 9.35%
610,422 $11.7 Million
Q1 2024

May 15, 2024
SELL
$29.41 - $34.72 $148,196 - $174,954
-5,039 Reduced 0.74%
673,386 $22.1 Million
Q4 2023

Feb 13, 2024
BUY
$23.63 - $33.52 $18,927 - $26,849
801 Added 0.12%
678,425 $22.4 Million
Q3 2023

May 14, 2024
SELL
$25.0 - $31.4 $20,025 - $25,151
-801 Reduced 0.12%
677,624 $18.5 Million
Q3 2023

Nov 14, 2023
SELL
$25.0 - $31.4 $1.63 Million - $2.05 Million
-65,206 Reduced 8.78%
677,624 $18.5 Million
Q2 2023

May 14, 2024
SELL
$28.05 - $36.44 $6.62 Million - $8.6 Million
-236,109 Reduced 24.12%
742,830 $22.5 Million
Q2 2023

Aug 14, 2023
SELL
$28.05 - $36.44 $6.62 Million - $8.6 Million
-236,109 Reduced 24.12%
742,830 $22.5 Million
Q1 2023

May 14, 2024
BUY
$26.35 - $35.8 $6.97 Million - $9.47 Million
264,520 Added 37.03%
978,939 $31.8 Million
Q1 2023

May 11, 2023
BUY
$26.35 - $35.8 $6.97 Million - $9.47 Million
264,520 Added 37.03%
978,939 $31.8 Million
Q4 2022

May 14, 2024
SELL
$22.21 - $37.41 $4.99 Million - $8.4 Million
-224,468 Reduced 23.91%
714,419 $20.1 Million
Q4 2022

Feb 13, 2023
SELL
$22.21 - $37.41 $4.99 Million - $8.4 Million
-224,468 Reduced 23.91%
714,419 $20.1 Million
Q3 2022

May 14, 2024
BUY
$29.37 - $39.74 $15.6 Million - $21.1 Million
530,556 Added 129.93%
938,887 $33.7 Million
Q3 2022

Nov 10, 2022
BUY
$29.37 - $39.74 $15.6 Million - $21.1 Million
530,556 Added 129.93%
938,887 $33.7 Million
Q2 2022

May 14, 2024
SELL
$25.9 - $32.26 $7 Million - $8.71 Million
-270,094 Reduced 39.81%
408,331 $12.5 Million
Q2 2022

Aug 15, 2022
BUY
$25.9 - $32.26 $6.74 Million - $8.39 Million
260,066 Added 175.41%
408,331 $12.5 Million
Q1 2022

May 16, 2022
BUY
$22.14 - $32.3 $1.12 Million - $1.63 Million
50,489 Added 51.64%
148,265 $4.79 Million
Q4 2021

Feb 14, 2022
BUY
$25.36 - $34.11 $533,244 - $717,230
21,027 Added 27.4%
97,776 $2.71 Million
Q3 2021

Nov 10, 2021
BUY
$20.93 - $31.0 $1.61 Million - $2.38 Million
76,749 New
76,749 $2.38 Million

Others Institutions Holding EVH

# of Institutions
298
Shares Held
122M
Call Options Held
2.12M
Put Options Held
2.53M
View Full List

About Evolent Health, Inc.

EVH Quotes by TradingView
  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $968M
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email